The model predictions agree well with the known mechanisms of dysregulations of insulin secretion, i.e., excessively high fasting levels and inadequate postprandial insulin secretion caused by the pathophysiological conditions of hyperlipidemia, and contribute to a better understanding of the general dysregulations of insulin signaling in obesity and T2DM. The gene discussed is INS; the disease is hyperlipidemia.